MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
FULC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fulcrum Therapeutics (FULC) Ownership - Who owns Fulcrum Therapeutics?

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
55
Web
https://www.fulcrumtx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
256.54M
P/E Ratio
N/A
Total Cash
333.32M
Projected Growth
N/A
Total Debt
5.87M
Revenue
N/A
Risk (Beta)
2.44
Dividend Yield
N/A
Total Cash/Share
5.00
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)
Annualized Return+18%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
FULC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for FULC
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

Industry Biotechnology

Profile
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
55
Web
https://www.fulcrumtx.com